Home›People›Yichao Fan
YF

Yichao Fan

Director, Rgenta Therapeutics, Inc.

Director
Updated Nov 6, 2026·Latest SEC filing Nov 3, 2026·Suggest an edit

About Yichao Fan

Yichao Fan is a director of Rgenta Therapeutics, Inc. The company develops RNA-targeting medicines for diseases that have been hard to treat with drugs.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Yichao Fan in the role, so the role may have started earlier or lasted longer.

Rgenta Therapeutics, Inc. Current
Director
2026 – Present · Woburn, MA
The company develops oral small-molecule drugs that target RNA to treat cancer and neurological diseases that current medicines cannot reach.

Key Colleagues at Startups

The people Yichao Fan works with at each company, as listed on that company's latest Form D.

Rgenta Therapeutics, Inc. · Form D, Nov 3, 2026
HX
Hualin Xi
Co-founder and CEO, director
SZ
Sean Zhang
Director and promoter
CK
Cillian King
Director and promoter
JK
Travis Wager
Travis Wager
Co-founder, President and CSO
ZW
Zhiping Weng
Director
Jeff Guckert
Jeff Guckert
Director of Finance

Sources

  1. SECRgenta Therapeutics, Inc. Form D, filed Nov 3, 2026
  2. press_releaseRgenta Therapeutics Launches with $20 Million Seed Investment